Regen Biopharma (RGBP)
OTHER OTC:RGBP
US Market
Holding RGBP?
Track your performance easily

Regen Biopharma (RGBP) Financial Statements

116 Followers

Regen Biopharma Financial Overview

Regen Biopharma's market cap is currently ―. The company's EPS TTM is $-0.118; its P/E ratio is -0.76; Regen Biopharma is scheduled to report earnings on May 14, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue$ 59.06K$ 59.06K$ 31.64K$ 59.06K$ 31.64K
Gross Profit$ 59.06K$ 31.64K$ 31.64K$ 59.06K$ 31.64K
EBIT$ -130.12K$ -101.07K$ -332.00K$ -99.22K$ -42.89K
EBITDA$ -125.78K$ -101.07K$ -327.63K$ -99.22K$ -42.89K
Net Income Common Stockholders$ -117.11K$ -122.47K$ -349.76K$ -99.22K$ -54.98K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 61.85K$ 78.11K$ 124.50K$ 692.00$ 87.70K
Total Assets$ 170.15K$ 140.77K$ 159.53K$ 285.20K$ 406.63K
Total Debt$ 500.88K$ 693.77K$ 704.07K$ 601.59K$ 601.59K
Net Debt$ 439.03K$ 615.66K$ 579.57K$ 600.90K$ 513.89K
Total Liabilities$ 5.33M$ 5.32M$ 5.40M$ 5.31M$ 5.34M
Stockholders Equity$ -5.16M$ -5.18M$ -5.24M$ -5.03M$ -4.93M
Cash Flow-
Free Cash Flow$ -172.59K$ -209.32K$ -162.34K$ -87.01K$ -53.04K
Operating Cash Flow$ -172.59K$ -209.32K$ -162.34K$ -87.01K$ -53.04K
Investing Cash Flow-----
Financing Cash Flow$ 156.32K$ 162.94K$ 165.80K-$ 100.00K
Currency in USD

Regen Biopharma Earnings and Revenue History

Regen Biopharma Debt to Assets

Regen Biopharma Cash Flow

Regen Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis